Search

Search results

215 results found

Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model.

Zhang, Xuefeng, Eric Galardi, Mark Duquette, Marko Delic, Jack Lawler, and Sareh Parangi. 2005. “Antiangiogenic Treatment With the Three Thrombospondin-1 Type 1 Repeats Recombinant Protein in an Orthotopic Human Pancreatic Cancer Model.”. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 11 (6): 2337-44.

Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells with BRAF(V600E): New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment.

Structural and immunological comparison of human thrombospondins isolated from platelets and from culture supernatants of endothelial cells and fibroblasts. Evidence for a thrombospondin polymorphism.

Clezardin, P, N R Hunter, J W Lawler, D A Pratt, J L McGregor, D S Pepper, and J Dawes. 1986. “Structural and Immunological Comparison of Human Thrombospondins Isolated from Platelets and from Culture Supernatants of Endothelial Cells and Fibroblasts. Evidence for a Thrombospondin Polymorphism.”. European Journal of Biochemistry 159 (3): 569-79.